Adam is a deep technical operator-turned-investor with 25-30 years in health tech and medical devices, including senior VP roles where he led a $170M acquisition and integrations totaling over $1B, giving him unusually rich buyer-side and M&A experience for a VC. He trains his entire investment thesis around the idea that virtually every major disruptive innovation traces back to a fundamental innovation in materials, treating material science as the DNA of the physical world rather than taking a broad deep tech approach. Adam is a deep technical operator-turned-investor with 25-30 years in health tech and medical devices, including senior VP roles where he led a $170M acquisition and integrations totaling over $1B, giving him unusually rich buyer-side and M&A experience for a VC. He trains his entire investment thesis around the idea that virtually every major disruptive innovation traces back to a fundamental innovation in materials, treating material science as the DNA of the physical world rather than taking a broad deep tech approach.